Top-News

NCI News

Keine aktuellen Kursdaten verfügbar
WKN: A0F6J2
ISIN: US62886K1043
US-Symbol: NCIT
Typ: Aktie

NCI News

08.08.17 - PR Newswire
Bernstein Liebhard LLP Announces Investigation Into The Proposed Sale Of NCI, Inc.
Bernstein Liebhard LLP Announces Investigation Into The Proposed Sale Of NCI, Inc. PR Newswire
02.08.17 - PR Newswire
Lifshitz & Miller LLP Announces Investigation of EZCORP, Inc., Flowserve Corporation, Halliburton Company, NCI, Inc., Parkway, Inc., United Therapeutics Corporation and ViewRay, Inc.
Lifshitz & Miller LLP Announces Investigation of EZCORP, Inc., Flowserve Corporation, Halliburton Company, NCI, Inc., Parkway, Inc., United Therapeutics Corporation and ViewRay, ...
10.07.17 - PR Newswire
WEISSLAW LLP: NCI, Inc. Acquisition May Not Be in the Best Interests of NCIT Shareholders
WEISSLAW LLP: NCI, Inc. Acquisition May Not Be in the Best Interests of NCIT Shareholders PR Newswire
10.07.17 - PR Newswire
Harwood Feffer LLP Announces Investigation of NCI, Inc.
Harwood Feffer LLP Announces Investigation of NCI, Inc. PR Newswire
05.07.17 - PR Newswire
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of NCI, Inc. - NCIT
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of NCI, Inc. - NCIT PR Newswire
03.07.17 - PR Newswire
NCI (NCIT) ALERT: J&W Investigates Proposed Sale of NCI, Inc.; Is $20 a Fair Price?
NCI (NCIT) ALERT: J&W Investigates Proposed Sale of NCI, Inc.; Is $20 a Fair Price? PR Newswire
03.02.17 - PR Newswire
Lifshitz & Miller LLP Announces Investigation of Dr. Reddy's Laboratories Limited, Exterran Corporation, Gigamon Inc., KemPharm, Inc., Navient Corporation, NCI, Inc., Opus Bank, PixarBio Corporati
Lifshitz & Miller LLP Announces Investigation of Dr. Reddy's Laboratories Limited, Exterran Corporation, Gigamon Inc., KemPharm, Inc., Navient Corporation, NCI, Inc., Opus Bank, ...
27.01.17 - PR Newswire
NCIT LOSS NOTICE: Rosen Law Firm Continues to Investigate Securities Claims Against NCI, Inc. - NCIT
NCIT LOSS NOTICE: Rosen Law Firm Continues to Investigate Securities Claims Against NCI, Inc. - NCIT PR Newswire
24.01.17 - PR Newswire
Harwood Feffer LLP Announces Investigation of NCI, Inc.
Harwood Feffer LLP Announces Investigation of NCI, Inc. PR Newswire
23.01.17 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NCI, Inc. - NCIT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NCI, Inc. - NCIT PR Newswire
05.10.15 - Börse Online
Evotec-Aktie legt zu - Zuschlag für die Verwaltung von Substanz-Bibliotheken
Der Zuschlag für die Verwaltung der Substanz-​Bibliotheken des National Cancer Institute Chemical Biology Consortium gibt Evotec am Montag Auftrieb. Die Aktien gewinnen 2,8 ...
17.02.12 - Aktiencheck
NCI Kursziel gesenkt - FBR Capital Markets
Die Analysten von FBR Capital Markets vergeben für die Aktie von NCI weiterhin das Votum "market perform". Das Kursziel werde von 22,00 USD auf 9,00 USD gesenkt. (Analyse ...
04.08.11 - Aktiencheck
NCI "hold" - Stifel Nicolaus
Rating-​Update: Baltimore (aktiencheck.de AG) - Die Analysten von Stifel Nicolaus stufen die Aktie von NCI von "buy" auf "hold" herab. (Analyse vom 04.08.2011) (04.08.2011/ac/a/u)
08.11.10 - Aktiencheck
NCI "buy" - Standpoint Research
Rating-​Update: Forest Hills (aktiencheck.de AG) - Die Analysten von Standpoint Research stufen die NCI-Aktie in einer Ersteinschätzung mit "buy" ein. Das Kursziel werde bei 29 ...

Newssuche

Videos

newspaper
24.04.24
Technical Trading: AUD/USD mit Mega Chance
AUD/USD Long Typ: Turbo Open End WKN: UM0EHU Hebel: 6,42 Laufzeit: OpenEnd Einstieg: Market ... Mehr »